Back to SYRE

PRICE T ROWE ASSOCIATES INC /MD/ → SYRE

PRICE T ROWE ASSOCIATES INC /MD/ SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
8
Latest value
$9.8M
Q3 2026
Peak value
$260.5M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$49.9M
Q4 2025$2.5M
Q1 2026$4.4M
Q1 2026$76.2M
Q2 2026$253.4M
Q2 2026$9.5M
Q3 2026$260.5M
Q3 2026$9.8M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$9.8M110.5K——
Q3 2026$260.5M2.93M——
Q2 2026$9.5M106.7K——
Q2 2026$253.4M2.85M——
Q1 2026$76.2M1.51M——
Q1 2026$4.4M88.0K——
Q4 2025$2.5M77.2K——
Q4 2025$49.9M1.52M——

Other funds holding SYRE

Other PRICE T ROWE ASSOCIATES INC /MD/ positions

NVDA

NVIDIA CORPORATION

$76.2B
NVDA

NVIDIA CORPORATION

$66.9B
NVDA

NVIDIA CORPORATION

$62.9B
NVDA

NVIDIA CORPORATION

$58.5B
MSFT

MICROSOFT CORP

$55.5B
AAPL

APPLE INC

$49.4B
AAPL

APPLE INC

$45.5B
AAPL

APPLE INC

$44.9B